Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability
- PMID: 6491903
- DOI: 10.1002/jps.2600730803
Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability
Abstract
Current understanding of the mechanism of corneal penetration by organic molecules proposes the epithelial layer as the rate-limiting membrane for water-soluble compounds and the stromal layer as rate limiting for lipid-soluble compounds. This suggests that the relationship between corneal permeability and the logarithm of oil/water partition coefficients, for a series of drugs, should not be the typical, single, continuous, parabolic-shaped curve. Corneal penetration studies have been conducted in unanesthetized albino rabbits using various organic compounds, representing five orders of magnitude in partition coefficient, at a constant concentration of 4 X 10(-5) M dispensed in either a 1- or 90-centipoise (cps) solution. It has been shown that for non-ionizable compounds, a pair of bell-shaped curves were generated, one for lipid-soluble and one for water-soluble compounds. Small water-soluble species demonstrate very high apparent permeabilities, which may relate to the presence of aqueous pores or other paracellular drug movement. Penetration of ionizable compounds does not appear to correlate well with the structural relationships invoked for un-ionized compounds. Consistent with the proposed mechanisms of corneal penetration, oil-soluble drug substances show no improvement in drug bioavailability when dosed from a 90-cps solution, and water-soluble drugs show a modest improvement in ocular drug bioavailability. Small water-soluble substances demonstrate no improvement due to their already high bioavailability. The importance of nonproductive absorption and precorneal drainage on bioavailability is addressed.
Similar articles
-
Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.J Pharm Sci. 1988 Jan;77(1):3-14. doi: 10.1002/jps.2600770103. J Pharm Sci. 1988. PMID: 3126290
-
Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.J Pharm Sci. 1977 Sep;66(9):1222-8. doi: 10.1002/jps.2600660905. J Pharm Sci. 1977. PMID: 20491
-
Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.Drug Deliv. 2018 Nov;25(1):938-949. doi: 10.1080/10717544.2018.1461278. Drug Deliv. 2018. PMID: 29658325 Free PMC article.
-
Clinical pharmacokinetics of the eye. Proctor lecture.Invest Ophthalmol Vis Sci. 1981 Oct;21(4):504-41. Invest Ophthalmol Vis Sci. 1981. PMID: 6116682 Review.
-
Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.Drug Dev Ind Pharm. 2002 Apr;28(4):353-69. doi: 10.1081/ddc-120002997. Drug Dev Ind Pharm. 2002. PMID: 12056529 Review.
Cited by
-
Clinical pharmacokinetics of various topical ophthalmic delivery systems.Clin Pharmacokinet. 1995 Aug;29(2):130-8. doi: 10.2165/00003088-199529020-00006. Clin Pharmacokinet. 1995. PMID: 7586901 Review.
-
Nanostructure-based platforms-current prospective in ophthalmic drug delivery.Indian J Ophthalmol. 2014 Jul;62(7):768-72. doi: 10.4103/0301-4738.138301. Indian J Ophthalmol. 2014. PMID: 25116766 Free PMC article. Review.
-
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations.Pharm Res. 2020 Nov 19;37(12):245. doi: 10.1007/s11095-020-02965-y. Pharm Res. 2020. PMID: 33215336 Free PMC article.
-
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview.Pharmaceutics. 2018 Sep 12;10(3):159. doi: 10.3390/pharmaceutics10030159. Pharmaceutics. 2018. PMID: 30213143 Free PMC article. Review.
-
Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives.Biomed Res Int. 2014;2014:263604. doi: 10.1155/2014/263604. Epub 2014 Jun 3. Biomed Res Int. 2014. PMID: 24995280 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources